Tero Firma - Part A Base

Hazard statements (CLP)

H315, H317, H319, H411

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP)] SECTION 2: 2.1. Hazards

2.1 Classification of the substance or mixture

Skin corrosion/irritation, Category 2 H315 Classification according to Regulation (EC) No. 1272/2008 [CLP] Serious eye damage/eye irritation, Category 2 H319 Skin corrosion/irritation, Category 2 Skin sensitisation, Category 1 H315 H317 Serious eye damage/eye irritation, Category 2 Hazardous to the aquatic environment – Chronic Hazard, Category 2 H319 H411 Skin sensitisation, Category 1 Full text of H- and EUH-statements: see section 16 H317 Hazardous to the aquatic environment – Chronic Hazard, Category 2 H411 Full text of H- and Adverse EUH-statements: physicochemical, see section human 16 health and environmental effects Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. Toxic to aquatic life with long lasting effects. Adverse physicochemical, human health and environmental effects Causes skin irritation. 2.2. Label May cause elements

Adverse physicochemical, human health and environmental effects

Causes skin irritation Label May cause elements an allergic skin reaction. Causes serious eye irritation. Toxic to aquatic life with long lasting effects

Hazard pictograms

GHS07 GHS09

Signal word

Warning

Contains

GHS07 Epoxy Polymer, Phenol-Formaldehyde Polymer, Alkyl Glycidyl Ether GHS09 Epoxy Polymer, Phenol-Formaldehyde Polymer, Alkyl Glycidyl Ether H317 - May cause an allergic skin reaction.

Hazard statements

Warning H315 - Causes skin irritation. H315 - Causes skin irritation. H319 - Causes serious eye irritation. H317 - May cause an allergic skin reaction. H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

H319 - Causes serious eye irritation. P261 - Avoid breathing vapours. H411 - Toxic to aquatic life with long lasting effects. P264 - Wash hands thoroughly after handling. P261 - Avoid breathing vapours. P280 - Wear eye protection, protective clothing, protective gloves. P264 - Wash hands P321 thoroughly - Specific treatment after handling. (see supplemental first aid instruction on this label). P280 - Wear eye P333+P313 protection, - protective If skin irritation clothing, or rash protective occurs: gloves. Get medical advice/attention. P321 - Specific P337+P313 treatment (see - If supplemental eye irritation persists: first aid instruction Get medical on advice/attention. this label). P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. 13/02/2024 (Revision date) P337+P313 - If eye irritation EN persists: (English) Get medical advice/attention. 1/12 Revision: 3.0 13/02/2024 (Revision date) EN (English) 1/12 P362+P364 - Take off contaminated clothing and wash it before reuse. P391 - Collect spillage.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %